Premium
Retinal detachments after Boston keratoprosthesis: incidence, predisposing factors and outcomes of repair
Author(s) -
JARDELEZA MS,
DOHLMAN CH,
YOUNG L
Publication year - 2009
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2009.2173.x
Subject(s) - retinal detachment , medicine , keratoprosthesis , retinal , etiology , ophthalmology , incidence (geometry) , eye disease , surgery , visual acuity , physics , optics
Abstract Purpose Knowledge of predisposing factors to retinal detachments in certain patient populations can guide surgical planning in Boston keratoprosthesis placement. Methods This is a retrospective, noncomparative, interventional case series. A review of 166 patients (203 eyes) who underwent Boston Keratoprosthesis implantation at the Massachusetts Eye and Ear Infirmary from 1993 to 2008 was performed. Most patients had very advanced ocular disease. Predisposing factors to retinal detachment and details of timing after surgery were investigated. Anatomical and visual outcomes of retinal detachment repair were analyzed. Results Table 1. Retinal detachment after K‐Pro implantation Category Number of Eyes Eyes with RD Autoimmune systemic disease 72 24 (33%) Chemical burns 14 3 (21%) Non‐autoimmune etiology 117 10 (8.5%) Eighty‐nine (89%) of patients with retinal detachments have visual outcomes of less than 20/200 despite surgical repair. Majority of retinal detachments in all three subgroups occurred within the first six months after K‐Pro placement. Conclusion These data suggest that a retinal detachment following K‐Pro implantation is more frequent in patients with autoimmune disease (where K‐Pro is generally not recommended). When they do occur, they portend a poor visual prognosis. Patients with underlying autoimmune systemic disorders should be warned of the higher risk of developing retinal detachments after keratoprosthetic surgery and warrant close co‐management with a vitreoretinal specialist.